Skip to main content
HLB Therapeutics Co.,Ltd. logo

HLB Therapeutics Co.,Ltd. — Investor Relations & Filings

Ticker · 115450 ISIN · KR7115450009 KO Manufacturing
Open in API
Filings indexed 444 across all filing types
Latest filing 2022-12-16 Notice of Dividend Amou…
Country KR South Korea
Listing KO 115450

About HLB Therapeutics Co.,Ltd.

https://hlbtherapeutics.co.kr/en/

HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.

Recent filings

Filing Released Lang Actions
주식배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement regarding a 'Stock Dividend Decision' (주식배당결정) by HLB Therapeutics. It details the number of shares to be issued as dividends, the record date, and the board resolution date. Since this document specifically announces the dividend amount and terms for shareholders, it falls under the 'Notice of Dividend Amount' category.
2022-12-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the administrative procedure for determining shareholder eligibility for the AGM. Given its nature as a regulatory notification regarding meeting preparation, it fits best under the RNS category.
2022-12-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details the share ownership, changes in holdings, and the purpose of holding (influence on management) by a specific entity (Nomad No. 1 Association) and its special related parties in HLB Therapeutics. This type of filing is classified as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2022-12-14 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for HLB Therapeutics, covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business operations, and management discussions, which is characteristic of an interim financial report. It is not an announcement of a report (RPA) or a simple certification, as it contains substantive financial data and business analysis. 9M 2022
2022-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the shareholding status, changes in ownership, and contractual relationships (such as call options on convertible bonds) of a major shareholder (Nomad No. 1 Association) in HLB Therapeutics. This falls under the category of Major Shareholding Notification.
2022-10-17 Korean
반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for HLB Therapeutics, covering the period from January 1, 2022, to June 30, 2022. It contains detailed financial information, business operations, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2022
2022-08-16 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.